每年專案
個人檔案
經歷
- 2023.08- 臺北醫學大學管理學院副院長
- 2023.08- 臺北醫學大學醫務管理學系主任
- 2020 臺北醫學大學醫務管理學系教授
- 2016 臺北醫學大學醫務管理學系副教授
指紋
查看啟用 Wei Pin Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
-
Trends in the incidence of head and neck cancer: A nationwide population-based study
Yang, T. H., Xirasagar, S., Cheng, Y. F., Chen, C. S., Chang, W. P. & Lin, H. C., 5月 2023, 於: Oral Oncology. 140, 106391.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders
Chiu, Y. C., Chang, W. P., Tang, G. J., Lan, T. Y., Lee, K. Y. & Su, V. Y. F., 6月 2022, 於: Respiratory Medicine. 197, 106833.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 引文 斯高帕斯（Scopus） -
Corrigendum to “Chronic obstructive pulmonary disease is associated with a higher risk of functional gastrointestinal disorders” [Respir. Med. 197 (2022) 106833] (Respiratory Medicine (2022) 197, (S0954611122000981), (10.1016/j.rmed.2022.106833))
Chiu, Y. C., Chang, W. P., Tang, G. J., Lan, T. Y., Lee, K. Y. & Su, V. Y. F., 8月 1 2022, 於: Respiratory Medicine. 200, 106893.研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
開啟存取 -
Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis
Adikusuma, W., Chou, W-H., Lin, M-R., Ting, J., Irham, L. M., Perwitasari, D. A., Chang, W-P. & Chang, W-C., 2022, 於: Biomedicines. 10, 1研究成果: 雜誌貢獻 › 文章 › 同行評審
11 引文 斯高帕斯（Scopus） -
An Assessment of the Interoperability of Electronic Health Record Exchanges Among Hospitals and Clinics in Taiwan
Wen, H-C., Chang, W-P., Hsu, M-H., Ho, C-H. & Chu, C. M., 1月 2021, 於: JMIR medical informatics. 7, 1, p. e12630 e12630.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取6 引文 斯高帕斯（Scopus）
資料集
-
Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y. (Creator), Li, W. (Contributor), Chang, Y. (Creator), Peng, C. (Creator), Cheng, C. (Contributor), Chang, W. P. (Creator) & Chuang, C. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3642380.v1, https://figshare.com/collections/Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/3642380/1
資料集: Dataset
-
Additional file 1: of Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
Chang, Y. (Creator), Li, W. (Contributor), Chang, Y. (Creator), Peng, C. (Creator), Cheng, C. (Contributor), Chang, W. P. (Creator) & Chuang, C. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3642380_d1.v1, https://springernature.figshare.com/articles/dataset/Additional_file_1_of_Front-line_intraperitoneal_versus_intravenous_chemotherapy_in_stage_III-IV_epithelial_ovarian_tubal_and_peritoneal_cancer_with_minimal_residual_disease_a_competing_risk_analysis/4462352/1
資料集: Dataset